Zhan‐Qi Cao

708 total citations
14 papers, 528 citations indexed

About

Zhan‐Qi Cao is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Zhan‐Qi Cao has authored 14 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and 2 papers in Genetics. Recurrent topics in Zhan‐Qi Cao's work include Galectins and Cancer Biology (5 papers), Protein Tyrosine Phosphatases (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Zhan‐Qi Cao is often cited by papers focused on Galectins and Cancer Biology (5 papers), Protein Tyrosine Phosphatases (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Zhan‐Qi Cao collaborates with scholars based in China and United Kingdom. Zhan‐Qi Cao's co-authors include Ping Leng, Xiuli Guo, Zhi Wang, Yanna Cheng, Lu‐Gang Yu, Xin‐Ke Zhang, Ying Zhang, Hui‐Hui Zhang, Lei Wang and Hongyuan Wang and has published in prestigious journals such as PLoS ONE, Frontiers in Pharmacology and Biomedicine & Pharmacotherapy.

In The Last Decade

Zhan‐Qi Cao

12 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhan‐Qi Cao China 10 275 112 110 104 53 14 528
Hae Jong Kim South Korea 15 318 1.2× 123 1.1× 92 0.8× 89 0.9× 55 1.0× 32 625
Jiao Li China 16 392 1.4× 107 1.0× 63 0.6× 132 1.3× 68 1.3× 31 686
Shailaja Hegde United States 17 338 1.2× 84 0.8× 122 1.1× 112 1.1× 36 0.7× 33 783
Namrata Rastogi India 14 379 1.4× 148 1.3× 97 0.9× 135 1.3× 68 1.3× 20 706
Mark Wade United States 13 314 1.1× 150 1.3× 98 0.9× 80 0.8× 68 1.3× 35 632
Chuanke Zhao China 14 364 1.3× 117 1.0× 60 0.5× 114 1.1× 35 0.7× 38 578
Taishu Wang China 10 427 1.6× 166 1.5× 90 0.8× 115 1.1× 59 1.1× 15 608
Yu-Chu Su Taiwan 15 297 1.1× 108 1.0× 108 1.0× 115 1.1× 60 1.1× 18 605
Sima Mansoori Derakhshan Iran 5 325 1.2× 69 0.6× 64 0.6× 103 1.0× 31 0.6× 22 533

Countries citing papers authored by Zhan‐Qi Cao

Since Specialization
Citations

This map shows the geographic impact of Zhan‐Qi Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhan‐Qi Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhan‐Qi Cao more than expected).

Fields of papers citing papers by Zhan‐Qi Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhan‐Qi Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhan‐Qi Cao. The network helps show where Zhan‐Qi Cao may publish in the future.

Co-authorship network of co-authors of Zhan‐Qi Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhan‐Qi Cao. A scholar is included among the top collaborators of Zhan‐Qi Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhan‐Qi Cao. Zhan‐Qi Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Li, Xiangpeng, H. Liang, Ping Leng, & Zhan‐Qi Cao. (2025). Safety assessment of obinutuzumab: Real-world adverse event analysis based on the FAERS and JADER databases from 2013 to 2025. PLoS ONE. 20(10). e0334317–e0334317.
2.
Cao, Zhan‐Qi, et al.. (2024). The regulating role of galectin-9 in immune cell populations. Frontiers in Pharmacology. 15. 1462061–1462061. 4 indexed citations
3.
Cao, Zhan‐Qi, et al.. (2023). Research progress on the role of PDGF/PDGFR in type 2 diabetes. Biomedicine & Pharmacotherapy. 164. 114983–114983. 23 indexed citations
4.
Sun, Jialin, Zhan‐Qi Cao, Shiwei Sun, et al.. (2022). Effects of 2,2',4'‑trihydroxychalcone on the proliferation, metastasis and apoptosis of A549 human lung cancer cells. Oncology Letters. 23(4). 116–116.
5.
6.
Cao, Zhan‐Qi, et al.. (2020). Research progress on the role of gal-3 in cardio/cerebrovascular diseases. Biomedicine & Pharmacotherapy. 133. 111066–111066. 19 indexed citations
7.
Cao, Zhan‐Qi, et al.. (2020). The roles of galectins in hepatic diseases. Journal of Molecular Histology. 51(5). 473–484. 13 indexed citations
8.
Cao, Zhan‐Qi, Zhi Wang, & Ping Leng. (2019). Aberrant N-cadherin expression in cancer. Biomedicine & Pharmacotherapy. 118. 109320–109320. 185 indexed citations
9.
Cao, Zhan‐Qi, Zhaojun Hao, Xin Ming, et al.. (2018). Endogenous and exogenous galectin-3 promote the adhesion of tumor cells with low expression of MUC1 to HUVECs through upregulation of N-cadherin and CD44. Laboratory Investigation. 98(12). 1642–1656. 13 indexed citations
10.
11.
Guo, Nan, Xiaoran Zhang, Zhan‐Qi Cao, et al.. (2017). Determination of brusatol in plasma and tissues by LC–MS method and its application to a pharmacokinetic and distribution study in mice. Journal of Chromatography B. 1053. 20–26. 10 indexed citations
12.
Zhou, Yue, Zhan‐Qi Cao, Hongyuan Wang, et al.. (2017). The anti-inflammatory effects of Morin hydrate in atherosclerosis is associated with autophagy induction through cAMP signaling. Molecular Nutrition & Food Research. 61(9). 1600966–1600966. 47 indexed citations
13.
Zhang, Hui‐Hui, Ying Zhang, Yanna Cheng, et al.. (2017). Metformin incombination with curcumin inhibits the growth, metastasis, and angiogenesis of hepatocellular carcinoma in vitro and in vivo. Molecular Carcinogenesis. 57(1). 44–56. 91 indexed citations
14.
Cao, Zhan‐Qi & Xiuli Guo. (2016). The role of galectin-4 in physiology and diseases. Protein & Cell. 7(5). 314–324. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hae Jong Kim Breakdown of academic impact, for papers by Jiao Li Breakdown of academic impact, for papers by Shailaja Hegde Breakdown of academic impact, for papers by Namrata Rastogi Breakdown of academic impact, for papers by Mark Wade Breakdown of academic impact, for papers by Chuanke Zhao Breakdown of academic impact, for papers by Taishu Wang Breakdown of academic impact, for papers by Yu-Chu Su Breakdown of academic impact, for papers by Sima Mansoori Derakhshan
Rankless by CCL
2026